David M. Burger

Research interests

Publications

• Recommendations for the Management of Drug–Drug Interactions Between the COVID ‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications

  Clinical Pharmacology & Therapeutics · 2022 · 10.1002/cpt.2646

• Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial

  The Lancet HIV · 2020 · 10.1016/s2352-3018(20)30050-3

• Dose recommendations for anticancer drugs in patients with renal or hepatic impairment

  The Lancet Oncology · 2019 · 10.1016/s1470-2045(19)30145-7

• Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials

  BMC Family Practice · 2017 · 10.1186/s12875-016-0577-x

• A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis

  American Journal of Respiratory and Critical Care Medicine · 2015 · https://doi.org/10.1164/rccm.201407-1264oc

• Antiretroviral Treatment of Adult HIV Infection

  JAMA · 2014 · 10.1001/jama.2014.8722

• Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs

  British Journal of Cancer · 2013 · 10.1038/bjc.2013.48

• Clinical management of drug–drug interactions in HCV therapy: Challenges and solutions

  Journal of Hepatology · 2012 · 10.1016/j.jhep.2012.10.027

• Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

  Clinical Infectious Diseases · 2009 · 10.1086/598327

• Therapeutic Drug Monitoring of Voriconazole

  Therapeutic Drug Monitoring · 2008 · 10.1097/ftd.0b013e31817b1a95

• Vitamin D Deficiency among HIV Type 1-Infected Individuals in the Netherlands: Effects of Antiretroviral Therapy

  AIDS Research and Human Retroviruses · 2008 · 10.1089/aid.2008.0058

• Rifampicin Reduces Plasma Concentrations of Moxifloxacin in Patients with Tuberculosis

  Clinical Infectious Diseases · 2007 · 10.1086/521894

• Long-Term Neuropsychiatric Disorders on Efavirenz-Based Approaches

  JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 10.1097/01.qai.0000147523.41993.47

• Evaluation of antiretroviral therapy results in a resource‐poor setting in Blantyre, Malawi

  Tropical Medicine & International Health · 2005 · 10.1111/j.1365-3156.2005.01409.x

• Interpatient variability in the pharmacokinetics of the HIV non‐nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism

  British Journal of Clinical Pharmacology · 2005 · 10.1111/j.1365-2125.2005.02536.x

• Pharmacokinetics of Adjusted-Dose Lopinavir-Ritonavir Combined with Rifampin in Healthy Volunteers

  Antimicrobial Agents and Chemotherapy · 2004 · 10.1128/aac.48.5.1553-1560.2004

• Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals

  AIDS · 2003 · 10.1097/00002030-200305230-00007

• Therapeutic Drug Monitoring

  Drugs · 2003 · 10.2165/00003495-200363080-00002

• Simultaneous Determination of the HIV Drugs Indinavir, Amprenavir, Saquinavir, Ritonavir, Lopinavir, Nelfinavir, the Nelfinavir Hydroxymetabolite M8, and Nevirapine in Human Plasma by Reversed-Phase High-Performance Liquid Chromatography

  Therapeutic Drug Monitoring · 2003 · 10.1097/00007691-200306000-00023

• Assessment of Adherence to HIV Protease Inhibitors: Comparison and Combination of Various Methods, Including MEMS (Electronic Monitoring), Patient and Nurse Report, and Therapeutic Drug Monitoring

  JAIDS Journal of Acquired Immune Deficiency Syndromes · 2002 · 10.1097/00126334-200207010-00009

• Prospective Randomized Two-Arm Controlled Study To Determine the Efficacy of a Specific Intervention To Improve Long-Term Adherence to Highly Active Antiretroviral Therapy

  JAIDS Journal of Acquired Immune Deficiency Syndromes · 2000 · 10.1097/00126334-200011010-00003

• Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients

  AIDS · 1999 · 10.1097/00002030-199903110-00005

• Adverse effects of reverse transcriptase inhibitors

  AIDS · 1998 · 10.1097/00002030-199814000-00004

• Antiretroviral drugs and the central nervous system

  AIDS · 1998 · 10.1097/00002030-199815000-00005

• Low Plasma Concentrations of Indinavir are Related to Virological Treatment Failure in HIV-1-Infected Patients on Indinavir-Containing Triple Therapy

  Antiviral Therapy · 1998 · 10.1177/135965359800300401

Current projects

No projects listed.